Related Experiment Video
Updated: Mar 21, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Astrocytic EAAT1 suppression by EV-ACLY underlies glutamate imbalance and cognitive impairment in POCD
Zheng Qi1,2, Lan Ding3, Yingying Zhao1,2
1Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China.
Abstract:
Postoperative cognitive dysfunction (POCD) is common in older surgical patients, yet its mechanistic underpinnings remain incompletely defined. Building on the premise that immune-cell metabolism shapes inflammatory signaling, we investigated whether microglia export metabolic instructions through extracellular vesicles (EVs) to remodel astrocytic function. We show that plasma EVs from POCD patients and EVs from activated microglia are enriched for ATP citrate lyase (ACLY) and are efficiently taken up by astrocytes. EV-delivered ACLY increases acetyl-CoA availability and enhances NF-κB p65 acetylation, which in turn suppresses the astrocytic glutamate transporter EAAT1 (SLC1A3). This program diminishes glutamate clearance, leading to synaptic dysfunction and cognitive impairment. In aged mice, systemic or hippocampal EV administration recapitulated microgliosis/astrogliosis, dendritic spine loss, impaired long-term potentiation, and deficits in the Morris water maze and novel object recognition. Chromatin immunoprecipitation confirmed acetyl-p65 occupancy at the SLC1A3 promoter, linking ACLY activity to direct transcriptional repression of EAAT1. Interventions that blocked EV biogenesis/uptake or reduced ACLY (genetically or pharmacologically) attenuated p65 acetylation, restored EAAT1 expression and glutamate uptake, and improved synaptic and behavioral outcomes. These findings identify a microglia-to-astrocyte ACLY-p65-EAAT1 axis that couples immunometabolism to excitatory neurotransmitter dysregulation and cognitive decline in POCD, highlighting ACLY and EV pathways as actionable therapeutic targets.
Insights
Microglia release extracellular vesicles (EVs) carrying ATP citrate lyase (ACLY) that impair astrocyte function, leading to cognitive decline in postoperative cognitive dysfunction (POCD). Targeting this pathway may improve brain function after surgery.
Area of Science:
- Neuroscience
- Immunology
- Metabolism
Background:
- Postoperative cognitive dysfunction (POCD) is a common complication in older adults undergoing surgery, with unclear underlying mechanisms.
- Immune cell metabolism is known to influence inflammatory signaling, but its role in POCD is not fully understood.
Purpose of the Study:
- To investigate if microglia-derived extracellular vesicles (EVs) transmit metabolic signals to astrocytes, affecting cognitive function.
- To elucidate the specific molecular mechanisms linking microglial metabolism to astrocytic function and cognitive impairment in POCD.
Main Methods:
- Analysis of plasma EVs from POCD patients and EVs from activated microglia for ATP citrate lyase (ACLY) content.
- In vitro studies using astrocytes to assess EV uptake and the functional consequences of EV-delivered ACLY.
- In vivo experiments in aged mice involving EV administration and assessment of neuroinflammation, synaptic function, and cognitive behaviors.
- Chromatin immunoprecipitation to confirm transcriptional regulation of EAAT1.
Main Results:
- EVs from POCD patients and activated microglia are enriched in ACLY and taken up by astrocytes.
- EV-delivered ACLY enhances NF-κB p65 acetylation, suppressing astrocytic glutamate transporter EAAT1 (SLC1A3) expression and impairing glutamate clearance.
- Systemic or hippocampal EV administration in aged mice induced POCD-like symptoms, including neuroinflammation, synaptic deficits, and cognitive impairment.
- Genetic or pharmacological inhibition of EV pathways or ACLY restored EAAT1 expression, glutamate uptake, and cognitive function.
Conclusions:
- A novel microglia-to-astrocyte signaling axis involving ACLY delivered via EVs contributes to cognitive decline in POCD.
- This pathway couples microglial immunometabolism to excitatory neurotransmitter dysregulation, offering potential therapeutic targets.
- Targeting ACLY and EV pathways presents a promising strategy for mitigating POCD and associated cognitive deficits.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Glutamate Antagonists

